References

  1. Hudson DL, Guy AT, Fry P, O’Hare MJ, Watt FM and Masters JRW. Epithelial cell differentiation pathways in the human prostate: Identification of intermediate phenotypes by keratin expression. J Histochem Cytochem. 2001; 49(2): 271-278. PubMed | Google Scholar

  2. Jemal A, Siegel R, Xu J and Ward E. Cancer statistics, 2010. Cancer J Clin. 2010; 60(5): 277-300. PubMed | Google Scholar

  3. Xue Y, Smedts F, Debruyne FMJ, de la Rosette JJ, Schalken JA. Identification of intermediate cell types by keratin expression in the developing prostate. Prostate. 1998; 34(4):292–301. PubMed | Google Scholar

  4. Hiyoshi O, Airo T, Akiharu O, Hideto S, Yuji N, Yosuke K and Sotokichi M. Keratin profile in normal/hyperplastic prostate and prostate carcinoma. Virchows Archiv A Pathol Anat. 1992; 421(2): 157-161. PubMed | Google Scholar

  5. Kai Hans H, Gustavo EA, Thomas MW. Application of Immunohistochemistry to the Genitourinary System (Prostate, Urinary Bladder, Testis, and Kidney). Arch Pathol Lab Med. 2008; 132(3): 432-440.. PubMed | Google Scholar

  6. Asim KM, Swapan P, Prosenjit G.,Diptendra KS, Anup KK. Study of Immunohistochemistry in Prostatic Lesions with Special Reference to Proliferation and Invasiveness Indian J Surg. 2011; 73(2):101–106. PubMed | Google Scholar

  7. Heatley M, Maxwell P, Whiteside C and Toner P. Vimentin and cytokeratin expression in nodular hyperplasia and carcinoma of the prostate. J Clin Pathol. 1995; 48(11): 1031-1034. PubMed | Google Scholar

  8. Van Muijen GNP, Ruiter DJ, Ponec M, Huiskens-Van Der Mey C, and Warnaar SO. Monoclonal antibodies with different specificities against cytokeratins. Am J Pathol. 1984 Jan;114(1):9-17. PubMed | Google Scholar

  9. Schlegel R, Banks-Schlegel S, and Pinkus GS. Immunohistochemical localization of keratin in normal human tissues. Lab Invest. 1980;42(1):91-96. PubMed | Google Scholar

  10. Barwick K, and Mardi A. An immunohistochemical study of the myoepithelial cell in prostate hyperplasia and neoplasia. Lab Invest. 1983;48:7A. PubMed | Google Scholar

  11. Gabbiani, G, Kapanci, Y, Barazzone P, and Franke WW. Immunochemical identification of intermediate-sized filaments in human neoplastic cells: a diagnostic aid for the surgical pathologist. Am J Pathol. 1981;104(3):206-216. PubMed | Google Scholar

  12. Michael KB, Donna MP, Thomas AS, et al. Keratin Immunoreactivity in the Benign and Neoplastic Human Prostate. Cancer Res. 1985; 45(8):3663-3667.. PubMed | Google Scholar

  13. Carme M, Mireia C, Vanesa M and Manel S. Immunohistochemical Expression of CK20, p53, and Ki-67 as Objective Markers of Urothelial Dysplasia. Mod Pathol. 2003;16(3):187–191. PubMed | Google Scholar

  14. Meral K, Isin K and Yener A. Evaluation of the proliferating activities of normal and carcinomatous prostatic tissues with Ki-67. Journal of Cell and Molecular Biology. 2005;4(2):107-111. PubMed | Google Scholar

  15. Hall PA, Levison DA. Assessment of cell proliferation in histologic material. J ClinPathol. 1990;43(3):184-192. PubMed | Google Scholar

  16. Bassily NH, Vallorosi CJ, Akdas G, Montie JE And Rubin MA. Coordinate Expression of Cytokeratins 7 and 20 in Prostate Adenocarcinoma and Bladder Urothelial Carcinoma. Am J Clin Pathol. 2000;113(3):383-388. PubMed | Google Scholar

  17. Schlegel R, Banks-Schlegel S, Mcleod JA, and Pinkus GS. Immunoperoxidase localization of keratin in human neoplasms. Am J Pathol. 1980;101(1):41-49. PubMed | Google Scholar

  18. Okada H, Tsubura A, Okamura A, Senzaki H, Naka Y, Komatz Y, Morii S. Keratin profiles in normal/hyperplastic prostates and prostate carcinoma. Virchows Arch A Pathol Anat. 1992; 421(2):157-161. PubMed | Google Scholar

  19. Verhagen APM, Frans CS, Ramaekers TW, Aalders H, Schaafsma E, Debruyne FMJ, Schalken JA. Colocalization of basal and luminal cell-type cytokeratins in human prostate cancer. Cancer Res. 1992; 52(22):6182-6187. PubMed | Google Scholar

  20. David Dabbs. Diagnostic Immunohistochemistry- 2nd edition.2006. Google Scholar

  21. Trompetter M, Smedts F, Van Der Wijk J, Schoots C, De Jong H J, Hopman A, and De La Rosette J. Keratin Profiling in the Developing Human Prostate: a Different Approach to Understanding Epithelial Lineage. Anticancer research. 2008;28(1A):237-243. PubMed | Google Scholar

  22. Gerdes J, Becker MHG, Keyt G, Cattoretti G. Immunohistochemical detection of tumor growth fraction (Ki-67 antigen) in formalin fixed and routinely processed tissue. J Pathol. 1992;168(1):85–87. PubMed | Google Scholar

  23. Tsuji M, Kojima K, Murakami Y, Kanayama H, Kagawa S. Prognostic value of Ki-67 antigen and p53 protein in urinary bladder cancer: immunohistochemical analysis of radical cystectomy specimens. Br J Urol. 1997; 79(3):367–72.. PubMed | Google Scholar

  24. Cina SJ, Lancaster-Weis KJ, Lecksell K, Epstein JI. Correlation of Ki-67 and p53 with the New World Health Organization/ International Society of urological pathology classification system for urothelial neoplasia. Arch Pathol Lab Med. 2001;125(5):646–51. PubMed | Google Scholar